Scientists probe gut hormones to unlock diabetes mystery in cystic fibrosis
NCT ID NCT01851694
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to understand why many people with cystic fibrosis develop diabetes. Researchers will give two gut hormones, GLP-1 and GIP, to 45 adults with cystic fibrosis and measure how their pancreas releases insulin. The goal is to learn more about cystic fibrosis-related diabetes and find better ways to treat it in the future.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
GLP-1 and GIP (hormones that boost insulin)
What this could lead to
If successful, this research could point toward new treatment options for cystic fibrosis-related diabetes.
What could go wrong
This is an early-stage observational study with only 45 participants, so results may not apply to everyone. It aims to understand the disease, not test a treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Children's Hospital of Philadelphia and University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19060, United States
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••